David Chernoff
- Virology top 0.5%
- HIV Research and Treatment 24
- Emergency Medicine top 1%
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 14
- HIV/AIDS Research and Interventions 8
- Hepatology top 2%
- Hepatitis C virus research 6
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies 15
-
- Vagus Nerve Stimulation Research 11
-
- Lymphoma Diagnosis and Treatment 11
-
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Morris SchambelanCarl GrünfeldViva TaiHeather A. AlgrenJoan C. LoKathleen MulliganHarry HollanderSean Farmer
- Journals
- Annals of the Rheumatic Diseases (11 papers)The Journal of Infectious Diseases (7 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (6 papers)
- Partner nations
- United StatesSwedenNetherlands
In The Last Decade
David Chernoff
66 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 115
- Virology 901
- Emergency Medicine 628
- Infectious Diseases 945
- Hepatology 370
- Rheumatology 456
Countries citing papers authored by David Chernoff
This map shows the geographic impact of David Chernoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chernoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chernoff more than expected).
Fields of papers citing papers by David Chernoff
This network shows the impact of papers produced by David Chernoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chernoff. The network helps show where David Chernoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Chernoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 33 | |
| 4 | 2023 | 0 | |
| 5 | 2020 | 81 | |
| 6 | 2018 | 8 | |
| 7 | 2018 | 8 | |
| 8 | 2014 | 69 | |
| 9 | 2013 | 1 | |
| 10 | 2013 | 130 | |
| 11 | 2012 | 1 | |
| 12 | A Multi-Biomarker Disease Activity (Vectra DA) Algorithm Score for Rheumatoid Arthritis Predicts Radiographic Progression in the BeSt Study | 2011 | 1 |
| 13 | 2002 | 52 | |
| 14 | 2001 | 102 | |
| 15 | 2001 | 87 | |
| 16 | 1998 | 14 | |
| 17 | 1997 | 28 | |
| 18 | 1995 | 24 | |
| 19 | 1993 | 16 | |
| 20 | 1992 | 67 |
About David Chernoff
David Chernoff is a scholar working on Virology, Neurology, Rheumatology, Infectious Diseases and Hepatology, having authored 69 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (24 papers), Rheumatoid Arthritis Research and Therapies (15 papers), HIV/AIDS drug development and treatment (14 papers), Vagus Nerve Stimulation Research (11 papers), Lymphoma Diagnosis and Treatment (11 papers), HIV/AIDS Research and Interventions (8 papers), Hepatitis C virus research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Virology (901 citations), Emergency Medicine (628 citations), Infectious Diseases (945 citations), Hepatology (370 citations) and Rheumatology (456 citations). David Chernoff has collaborated with scholars based in United States, Sweden and Netherlands. Frequent co-authors include Morris Schambelan, Carl Grünfeld, Viva Tai, Heather A. Algren, Joan C. Lo, Kathleen Mulligan, Harry Hollander, Sean Farmer, Glenn R. Gibson and David Keller. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, PLoS ONE and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.